| DC Field | Value | Language |
|---|
| dc.contributor.author | Bratchikov, O. I. | - |
| dc.contributor.author | Tyuzikov, I. A. | - |
| dc.contributor.author | Artishchev, S. O. | - |
| dc.date.accessioned | 2022-04-24T12:25:45Z | - |
| dc.date.available | 2022-04-24T12:25:45Z | - |
| dc.date.issued | 2019 | - |
| dc.identifier.citation | Bratchikov, O.I. Optimization of pharmacotherapy of patients with prostate adenoma with hormonal and metabolic disordes: correction of vitamin D deficiency with "Aquadetrim" / O.I. Bratchikov, I.A. Tyuzikov, S.O. Artishchev // Research Results in Pharmacology. - 2019. - Vol. 5, № 4.- P. 57-67. - Doi: 10.3897/rrpharmacology.5.49414. - Refer.: p. 66-67. | ru |
| dc.identifier.uri | http://dspace.bsu.edu.ru/handle/123456789/46320 | - |
| dc.description.abstract | The article notes that modern studies demonstrate an epidemiological and pathogenetic role of systemic hormonal and metabolic disorders in men with prostate adenoma (PA), so it is obvious that a pharmacotherapeutic correction of these disorders can increase the efficacy of the traditional therapy of the disease | ru |
| dc.language.iso | en | ru |
| dc.subject | medicine | ru |
| dc.subject | pharmacology | ru |
| dc.subject | prostate adenoma | ru |
| dc.subject | lower urinary tract symptoms (LUTS) | ru |
| dc.subject | nocturia | ru |
| dc.subject | metabolic syndrome | ru |
| dc.subject | obesity | ru |
| dc.subject | insulin resistance | ru |
| dc.subject | testosterone deficiency | ru |
| dc.subject | vitamin D deficiency | ru |
| dc.subject | pharmacotherapy | ru |
| dc.subject | optimization | ru |
| dc.subject | integrative approach | ru |
| dc.title | Optimization of pharmacotherapy of patients with prostate adenoma with hormonal and metabolic disordes: correction of vitamin D deficiency with "Aquadetrim" | ru |
| dc.type | Article | ru |
| Appears in Collections: | Vol. 5, № 4
|
